T1	Participants 0 142	EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
#1	AnnotatorNotes T1	Only the title was available. No participant information.
